Ying-chun XU, Jing-jing HUANG, Meng XIAO, Xin-fei CHEN, Ya-ting NING, Xin FAN, Yang YANG, Jia-jia FENG, Li-kai LIN. Current Status of Clinical Infection of Candida Auris in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 442-445. doi: 10.3969/j.issn.1674-9081.2019.05.003
Citation: Ying-chun XU, Jing-jing HUANG, Meng XIAO, Xin-fei CHEN, Ya-ting NING, Xin FAN, Yang YANG, Jia-jia FENG, Li-kai LIN. Current Status of Clinical Infection of Candida Auris in China[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 442-445. doi: 10.3969/j.issn.1674-9081.2019.05.003

Current Status of Clinical Infection of Candida Auris in China

doi: 10.3969/j.issn.1674-9081.2019.05.003
More Information
  • Corresponding author: LIN Li-kai Tel: 86-27-67813059, E-mail:1875278110@qq.com
  • Received Date: 2019-04-25
  • Publish Date: 2019-09-30
  • Candida auris is an emerging pathogen in recent years that has developed resistance and caused nosocomial outbreaks in some countries especially in the United States. The term "super fungi" derived from "superbug", and it is rarely mentioned in the field of fungi. However, recently the articles with the definition that "Candida auris is a super fungi" are widely circulated on the internet. The situation of Candida auris in China differs from that in the United States according to existing reports and epidemiological surveillance data. The infection caused by it is still sporadic, and isolations of Candida auris are active to antifungal agents. Meanwhile, its pathogenicity is not stronger than the common non-albican Candida species. Therefore, the public should avoid excessive interpretation of the articles with unnecessary panic.
  • loading
  • [1] WHO. Antimicrobial resistance: no action today, no cure tomorrow[EB/OL]. https://www.who.int/world-health-day/2011/en/.
    [2] 国家卫生健康委员会.国家卫生健康委办公厅关于持续做好抗菌药物临床应用管理工作的通知[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/201903/1d487eb7b7c74abc9fcb104f8b0905f2.shtml.
    [3] Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital[J]. Microbiol Immunol, 2009, 53:41-44. doi:  10.1111/j.1348-0421.2008.00083.x
    [4] US CDC. Global Emergence of Invasive Infections Caused by the Multidrug-Resistant Yeast Candida auris[EB/OL].https://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html.
    [5] US CDC. Tracking Candida auris [EB/OL]. https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html.
    [6] Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses[J]. Clin Infect Dis, 2017, 64:134-140. doi:  10.1093/cid/ciw691
    [7] Clancy CJ, Nguyen MH. Emergence of Candida auris:An International Call to Arms[J]. Clin Infect Dis, 2017, 64:141-143. doi:  10.1093/cid/ciw696
    [8] Eyre DW, Sheppard AE, Madder H, et al. A Candida auris Outbreak and Its Control in an Intensive Care Setting[J]. N Engl J Med, 2018, 379:1322-1331. doi:  10.1056/NEJMoa1714373
    [9] Tang HJ, Lai CC, Lai FJ, et al. Emergence of multidrug-resistant Candida auris in Taiwan[J]. Int J Antimicrob Agents, 2019, 53:705-706. doi:  10.1016/j.ijantimicag.2019.02.011
    [10] Chen Y, Zhao J, Han L, et al. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China[J]. J Infect, 2018, 77:561-571. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=506e946cddd09b4180b73fbd11b6105b
    [11] Tian S, Rong C, Nian H, et al. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China[J]. Emerg Microbes Infect, 2018, 7:128.
    [12] Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China:clinical and biological aspects[J]. Emerg Microbes Infect, 2018, 7:93. https://www.ncbi.nlm.nih.gov/pubmed/29777096
    [13] 郭晶.构建合理用药"金标准":北京协和医院开展临床重要致病性真菌新型诊断技术及全国多中心监测[J].协和医学杂志, 2013, 4:244. http://www.cnki.com.cn/Article/CJFDTotal-XHYX201303009.htm
    [14] Xiao M, Sun ZY, Kang M, et al. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study[J]. J Clin Microbiol, 2018, 56. pii: e00577-18.
    [15] Wang H, Zhang L, Kudinha T, et al. Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China[J]. Sci Rep, 2016, 6:27099. doi:  10.1038/srep27099
    [16] Hou X, Xiao M, Chen SC, et al. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China[J]. J Clin Microbiol, 2016, 54:2676-2680. doi:  10.1128/JCM.01492-16
    [17] Adams E, Quinn M, Tsay S, et al. Candida auris in Healthcare Facilities, New York, USA, 2013-2017[J]. Emerg Infect Dis, 2018, 24:1816-1824. doi:  10.3201/eid2410.180649
    [18] Montagna MT, Caggiano G, Lovero G, et al. Epidemiology of invasive fungal infections in the intensive care unit:results of a multicenter Italian survey (AURORA Project)[J]. Infection, 2013, 41:645-653. doi:  10.1007/s15010-013-0432-0
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1133) PDF downloads(258) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return